Aminologics Co.,Ltd.

KOSDAQ:A074430 Stock Report

Market Cap: ₩116.5b

AminologicsLtd Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for AminologicsLtd.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Chemicals earnings growth65.3%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Analysis Article • Jan 21

AminologicsLtd (KOSDAQ:074430) Shareholders Will Want The ROCE Trajectory To Continue

There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...
Analysis Article • Dec 30

AminologicsLtd (KOSDAQ:074430) Has A Rock Solid Balance Sheet

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Analysis Article • Dec 30

Subdued Growth No Barrier To Aminologics Co.,Ltd. (KOSDAQ:074430) With Shares Advancing 27%

Aminologics Co.,Ltd. ( KOSDAQ:074430 ) shares have had a really impressive month, gaining 27% after a shaky period...
Analysis Article • Nov 21

AminologicsLtd's (KOSDAQ:074430) Earnings Seem To Be Promising

The market seemed underwhelmed by last week's earnings announcement from Aminologics Co.,Ltd. ( KOSDAQ:074430 ) despite...
Analysis Article • Nov 12

Risks To Shareholder Returns Are Elevated At These Prices For Aminologics Co.,Ltd. (KOSDAQ:074430)

When close to half the companies in the Chemicals industry in Korea have price-to-sales ratios (or "P/S") below 0.7x...
Analysis Article • Nov 15

There May Be Underlying Issues With The Quality Of AminologicsLtd's (KOSDAQ:074430) Earnings

Despite announcing strong earnings, Aminologics Co.,Ltd.'s ( KOSDAQ:074430 ) stock was sluggish. We think that the...
Analysis Article • Aug 13

AminologicsLtd (KOSDAQ:074430) May Have Issues Allocating Its Capital

To avoid investing in a business that's in decline, there's a few financial metrics that can provide early indications...
Analysis Article • Mar 27

AminologicsLtd's (KOSDAQ:074430) Shareholders May Want To Dig Deeper Than Statutory Profit

Following the solid earnings report from Aminologics Co.,Ltd. ( KOSDAQ:074430 ), the market responded by bidding up the...
Analysis Article • Mar 01

Some Investors May Be Worried About AminologicsLtd's (KOSDAQ:074430) Returns On Capital

When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...
Analysis Article • May 05

Returns At AminologicsLtd (KOSDAQ:074430) Are On The Way Up

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analysis Article • Mar 19

Should Weakness in Aminologics Co.,Ltd.'s (KOSDAQ:074430) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

With its stock down 7.9% over the past three months, it is easy to disregard AminologicsLtd (KOSDAQ:074430). But if you...
Analysis Article • Feb 04

If You Had Bought AminologicsLtd (KOSDAQ:074430) Stock Five Years Ago, You Could Pocket A 137% Gain Today

When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really...

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as AminologicsLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A074430 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202522,0203,5222,4952,541N/A
9/30/202519,5161,9521,2541,489N/A
6/30/202515,905-9426,4936,961N/A
3/31/202516,581-5811,3141,782N/A
12/31/202416,790-1,6206,9967,466N/A
9/30/202420,8861,8575,9116,148N/A
6/30/202422,6622,8373,9804,025N/A
3/31/202421,7262,5752,4032,475N/A
12/31/202320,8872,436-374-218N/A
9/30/202318,798-13,256181735N/A
6/30/202322,265-10,1221,3861,902N/A
3/31/202323,275-9,3576,5097,016N/A
12/31/202227,337-7,2824,7235,226N/A
9/30/202227,8565,7464,7674,931N/A
6/30/202224,6334,1286,0936,395N/A
3/31/202226,6027,7173,1503,437N/A
12/31/202122,8495,360402936N/A
9/30/202120,5967,3212,9933,466N/A
6/30/202121,3697,073390977N/A
3/31/202117,9963,442-405240N/A
12/31/202017,6512,1401,4531,768N/A
9/30/202018,312-1,468-129188N/A
6/30/202017,219-2,1802,0052,079N/A
3/31/202017,570-2,7891,6441,658N/A
12/31/201918,980-1,2013,4983,604N/A
9/30/201918,9645,909N/A3,175N/A
6/30/201919,2266,864N/A3,892N/A
3/31/201920,0618,182N/A3,803N/A
12/31/201818,4507,996N/A4,558N/A
9/30/201817,7582,977N/A5,111N/A
6/30/201817,3352,307N/A3,455N/A
3/31/201816,638883N/A4,743N/A
12/31/201716,835542N/A3,000N/A
9/30/201716,463-3,569N/A4,045N/A
6/30/201716,845-3,520N/A3,345N/A
3/31/201716,541-3,602N/A2,866N/A
12/31/201616,366-3,742N/A4,138N/A
9/30/201618,3262,891N/A6,583N/A
6/30/201617,1612,990N/A5,716N/A
3/31/201614,050-1,447N/A3,987N/A
12/31/201510,997-2,825N/A1,929N/A
9/30/20156,404-10,069N/A-2,898N/A
6/30/20154,033-11,350N/A-1,606N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A074430's forecast earnings growth is above the savings rate (3.1%).

Earnings vs Market: Insufficient data to determine if A074430's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A074430's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A074430's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A074430's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if A074430's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/08 14:19
End of Day Share Price 2026/05/08 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Aminologics Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.